GlaxoSmithKline to acquire Tesaro for $4.16 billion
December 03, 2018 at 08:44 AM EST
The British pharmaceutical company has agreed to buy oncology-focused Tesaro.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|